Paxista – Nirmatrelvir 150 mg & Ritonavir 100 mg (Paxlovid Generic)

About Paxista – Nirmatrelvir 150 mg & Ritonavir 100 mg (Paxlovid Generic)

Paxista – Nirmatrelvir 150 mg & Ritonavir 100 mg (Paxlovid Generic) is supplied as combi-pack tablets containing Nirmatrelvir 150mg + Ritonavir 100mg, manufactured by Hetero Healthcare. It is indicated for the treatment and management of mild-to-moderate covid-19 treatment in high-risk adults.

Paxista – Nirmatrelvir 150 mg & Ritonavir 100 mg (Paxlovid Generic) is a high-quality bioequivalent generic of Paxlovid. It contains the exact same active therapeutic ingredient at identical strength, providing equal clinical efficacy at a fraction of the brand-name cost.

Product Specifications & Details

• Generic Name: Nirmatrelvir & Ritonavir
• Composition: Nirmatrelvir 150mg + Ritonavir 100mg
• Dosage Form: Combi-Pack Tablets
• Manufacturer: Hetero Healthcare
• Equivalent Brand: Paxlovid
• Indication: Mild-to-Moderate COVID-19 Treatment in High-Risk Adults
• Packaging: 30 Tablets in 1 Dose Pack (5-Day Treatment Course)

Usage & Storage Guidelines

Take strictly as directed by a healthcare professional. Store at room temperature away from heat, moisture, and direct sunlight. Keep out of reach of children.